Literature DB >> 15213100

Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops.

Georgi Guruli1, Beth R Pflug, Stefana Pecher, Valeria Makarenkova, Michael R Shurin, Joel B Nelson.   

Abstract

The biologic effects of endothelin-1 (ET-1) are not limited to its potent vasoconstricting activity. The endothelin receptors, ETA and ETB, have differential tissue and functional distributions. Here we showed that dendritic cells (DCs), the major antigen-presenting cells in the adaptive limb of the immune system, produce large amounts of ET-1 and significantly increase the expression of endothelin receptors upon maturation. Selective blockade of the ETA receptor significantly reduced expression of the mature DC marker CD83, decreased the production of the immunostimulatory cytokine interleukin-12, down-regulated DC ability to stimulate T cells, and promoted DC apoptosis. Selective ETB receptor blockade, on the other hand, resulted in increased expression of CD83 and improved DC survival. Therefore, ET-1/ETA/ETB autocrine/paracrine loops on DCs appear to be essential for the normal maturation and function of human DCs, presenting a unique target for immunomodulatory therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213100     DOI: 10.1182/blood-2003-10-3559

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes.

Authors:  Paula B Donate; Thiago M Cunha; Waldiceu A Verri; Cristina M Junta; Flavia O Lima; Silvio M Vieira; Rafael S Peres; Karina F Bombonato-Prado; Paulo Louzada; Sergio H Ferreira; Eduardo A Donadi; Geraldo A S Passos; Fernando Q Cunha
Journal:  Inflamm Res       Date:  2012-01-17       Impact factor: 4.575

Review 2.  Role of the endothelin axis and its antagonists in the treatment of cancer.

Authors:  A Bagnato; M Loizidou; B R Pflug; J Curwen; J Growcott
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 3.  Endothelin 1 in cancer: biological implications and therapeutic opportunities.

Authors:  Laura Rosanò; Francesca Spinella; Anna Bagnato
Journal:  Nat Rev Cancer       Date:  2013-07-25       Impact factor: 60.716

4.  B-lymphocyte-intrinsic and -extrinsic defects in secretory immunoglobulin A production in the neural crest-conditional deletion of endothelin receptor B model of Hirschsprung-associated enterocolitis.

Authors:  Giuliana Medrano; Frederic Cailleux; Peihong Guan; Korah Kuruvilla; Amanda J Barlow-Anacker; Ankush Gosain
Journal:  FASEB J       Date:  2019-03-25       Impact factor: 5.191

Review 5.  Endothelin-1 and the kidney--beyond BP.

Authors:  Neeraj Dhaun; David J Webb; David C Kluth
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

6.  Neural peptidase endothelin-converting enzyme 1 regulates endothelin 1-induced pruritus.

Authors:  Makiko Kido-Nakahara; Jörg Buddenkotte; Cordula Kempkes; Akihiko Ikoma; Ferda Cevikbas; Tasuku Akiyama; Frank Nunes; Stephan Seeliger; Burcu Hasdemir; Christian Mess; Timo Buhl; Mathias Sulk; Frank-Ulrich Müller; Dieter Metze; Nigel W Bunnett; Aditi Bhargava; Earl Carstens; Masutaka Furue; Martin Steinhoff
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

Review 7.  Is hypertension an immunologic disease?

Authors:  David G Harrison; Tomasz J Guzik; Jorg Goronzy; Cornelia Weyand
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

8.  Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.

Authors:  Tina L Sumpter; Anil Dangi; Benjamin M Matta; Chao Huang; Donna B Stolz; Yoram Vodovotz; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

Review 9.  Endothelin therapeutics in cancer: Where are we?

Authors:  Laura Rosanò; Anna Bagnato
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-27       Impact factor: 3.619

10.  Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells.

Authors:  Lan Coffman; Collin Mooney; Jaeyoung Lim; Shoumei Bai; Ines Silva; Yusong Gong; Kun Yang; Ronald J Buckanovich
Journal:  Cancer Biol Ther       Date:  2012-11-28       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.